BioVentix PLC Director/PDMR Shareholdings and Issue of Equity (9459Z)

TIDMBVXP

RNS Number : 9459Z

BioVentix PLC

19 May 2023

Bioventix plc

("Bioventix" or the "Company")

Director/PDMR Shareholdings and Issue of Equity

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, was notified on 18 May 2023 of the following transactions in its ordinary shares of 5 pence each ("Ordinary Shares"):

 
 Director         Role                    Options   Ordinary         Average               Ordinary       Percentage 
                                    over Ordinary     Shares      sale price    Shares subsequently        of issued 
                                           Shares       sold    per Ordinary                   held    share capital 
                                        exercised                      Share                            subsequently 
                                                                                                                held 
                  Non-Executive 
 Ian Nicholson     Chairman                 1,638      1,638        3,651.53                 13,000             0.2% 
                 ---------------  ---------------  ---------  --------------  ---------------------  --------------- 
 

The options over Ordinary Shares ("Options") were exercised at a price of 1350 pence per Ordinary Share pursuant to the Company's 2013 EMI Share Option Scheme, details of which can be found at www.bioventix.com . In addition, a current employee exercised 2,333 Options.

Issue of Equity

The Company has applied for 3,971 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur and that dealings will commence in the new Ordinary Shares on 25 May 2023. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

The total number of Ordinary Shares in issue following Admission will be 5,219,656 and the Company holds no shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 5,219,656.

The above figure of 5,219,656 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Bioventix under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

 
 Bioventix plc                                         Tel: [phone] 
  Peter Harrison             Chief Executive Officer 
  Bruce Hiscock              Chief Financial Officer 
 
 finnCap Ltd                                           Tel: [phone] 
  Geoff Nash/Simon Hicks     Corporate Finance 
  Alice Lane                 ECM 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       ("PDMR") / person closely associated ("PCA") 
 a)   Name                             Ian Nicholson 
     -------------------------------  ---------------------------------- 
 2.   Reason for the Notification 
     ------------------------------------------------------------------- 
 a)   Position/status                  Chairman 
     -------------------------------  ---------------------------------- 
 b)   Initial notification/Amendment   Initial notification 
     -------------------------------  ---------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                             Bioventix plc 
     -------------------------------  ---------------------------------- 
 b)   LEI                              213800225MHX7LZQY108 
     -------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of the               Ordinary Shares of 5 pence each 
       Financial instrument, 
       type of instrument 
      Identification code              GB00B4QVDF07 
     -------------------------------  ---------------------------------- 
 b)   Nature of the transaction        Exercise of Options over Ordinary 
                                        Shares 
     -------------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)            Price(s)   Volume(s) 
                                         1,350p     1,638 
                                                   ---------- 
     -------------------------------  ---------------------------------- 
 d)        Aggregated information:     See 4(c) 
             *    Aggregated volume 
 
 
             *    Price 
     -------------------------------  ---------------------------------- 
 e)   Date of the transaction          18 May 2023 
     -------------------------------  ---------------------------------- 
 f)   Place of the transaction         Off market transaction 
     -------------------------------  ---------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities 
       ("PDMR") / person closely associated ("PCA") 
 a)   Name                             Ian Nicholson 
     -------------------------------  ---------------------------------- 
 2.   Reason for the Notification 
     ------------------------------------------------------------------- 
 a)   Position/status                  Chairman 
     -------------------------------  ---------------------------------- 
 b)   Initial notification/Amendment   Initial notification 
     -------------------------------  ---------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                             Bioventix plc 
     -------------------------------  ---------------------------------- 
 b)   LEI                              213800225MHX7LZQY108 
     -------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of the               Ordinary Shares of 5 pence each 
       Financial instrument, 
       type of instrument 
      Identification code              GB00B4QVDF07 
     -------------------------------  ---------------------------------- 
 b)   Nature of the transaction        Sale of Ordinary Shares 
     -------------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)            Price(s)    Volume(s) 
                                         3,651.53p   1,638 
                                                    ---------- 
     -------------------------------  ---------------------------------- 
 d)        Aggregated information:     See 4(c) 
             *    Aggregated volume 
 
 
             *    Price 
     -------------------------------  ---------------------------------- 
 e)   Date of the transaction          18 May 2023 
     -------------------------------  ---------------------------------- 
 f)   Place of the transaction         London Stock Exchange, AIM Market 
                                        (XLON) 
     -------------------------------  ---------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUWRNROSUVAAR

(END) Dow Jones Newswires

May 19, 2023 02:00 ET (06:00 GMT)